New Delhi, Dec 24 (IANS) A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).The team from the University of California-Davis, US, tested an anti-inflammatory and anti-fibrotic monoclonal antibody known as nebokitug and found it to be safe and potentially effective in patients with PSC.Published in the American Journal of Gastroenterology, the results offer encouraging news for patients with PSC, for which there are…
Trending
- Jeena Dil Se (2026) Review: A Colorful Musical Entertainer That Celebrates Life, Love & Friendship
- Phera Movie Review: Sanjay Mishra and Ritwick Chakraborty Deliver a Quietly Devastating Father-Son Drama
- Sandigdham Review: A Gripping Mystery Thriller That Slowly Gets Under Your Skin
- Mareechika (2026) Review: A Psychological Thriller That Weaves Mystery and Emotion Into a Compelling Cinematic Experience
- Krishna Aur Chitthi Review: Arun Govil and Darsheel Safary Deliver a Heartfelt Tale of Faith, Family, and Cricket
- Return Of The Jungle (2026) Movie Review: A Heartwarming Animated Journey Rooted in Indian Storytelling
- Shape of Momo Review: A Breathtaking Portrait of Womanhood, Patriarchy, and Belonging in the Hills of Sikkim
- Rajni Ki Baraat Review (2026): A Bold, Heartwarming Celebration of Female Courage from the Lanes of Darbhanga